CETP inhibition

Lancet. 2007 Dec 8;370(9603):1882-3. doi: 10.1016/S0140-6736(07)61788-7.
No abstract available

Publication types

  • Comment
  • Randomized Controlled Trial

MeSH terms

  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / pharmacology
  • Anticholesteremic Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors*
  • Cholesterol, HDL / drug effects
  • Cholesterol, LDL / drug effects
  • Double-Blind Method
  • Dyslipidemias / complications
  • Dyslipidemias / drug therapy*
  • Humans
  • Quinolines / adverse effects
  • Quinolines / pharmacology
  • Quinolines / therapeutic use*

Substances

  • Anticholesteremic Agents
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Quinolines
  • torcetrapib